Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;113:2630-2641
Published online before print May 30, 2006, doi: 10.1161/CIRCULATIONAHA.105.609008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
113/22/2630    most recent
CIRCULATIONAHA.105.609008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bonnet, S.
Right arrow Articles by Archer, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonnet, S.
Right arrow Articles by Archer, S. L.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DICHLOROACETIC ACID
*OXYGEN
Medline Plus Health Information
*Pulmonary Hypertension
Related Collections
Right arrow Remodeling
Right arrow Animal models of human disease
Right arrow Developmental biology
Right arrow Ion channels/membrane transport
Right arrow Pulmonary circulation and disease
Right arrow Genetics of cardiovascular disease

(Circulation. 2006;113:2630-2641.)
© 2006 American Heart Association, Inc.


Vascular Medicine

An Abnormal Mitochondrial–Hypoxia Inducible Factor-1{alpha}–Kv Channel Pathway Disrupts Oxygen Sensing and Triggers Pulmonary Arterial Hypertension in Fawn Hooded Rats

Similarities to Human Pulmonary Arterial Hypertension

Sébastien Bonnet, PhD; Evangelos D. Michelakis, MD; Christopher J. Porter, BSc; Miguel A. Andrade-Navarro, BA, PhD; Bernard Thébaud, MD, PhD; Sandra Bonnet, MS; Alois Haromy, BSc; Gwyneth Harry, BSc; Rohit Moudgil, MS; M. Sean McMurtry, MD; E. Kenneth Weir, MD; Stephen L. Archer, MD

From the Vascular Biology Group, Division of Cardiology (S.B., E.D.M., B.T., S.B., A.H., G.H., R.M., M.S.M., S.L.A.), Physiology Department (S.L.A.), and Department of Pediatrics (B.T.), University of Alberta, Edmonton, Canada; Department of Medicine (Cardiology) (E.K.W.), Minneapolis Veterans Affairs Medical Center, Minneapolis, Minn; and Ontario Genomics Innovation Centre (C.J.P., M.A.A.-N.), Ottawa Health Research Institute, Ottawa, Ontario.

Correspondence to Stephen L. Archer, MD, FRCP, FAHA, University of Alberta, WMC 2C2.36, 8440 112th St, Edmonton, Alberta, Canada T6G 2B7. E-mail sarcher{at}cha.ab.ca

Received December 19, 2005; revision received March 31, 2006; accepted April 3, 2006.

Background— The cause of pulmonary arterial hypertension (PAH) was investigated in humans and fawn hooded rats (FHR), a spontaneously pulmonary hypertensive strain.

Methods and Results— Serial Doppler echocardiograms and cardiac catheterizations were performed in FHR and FHR/BN1, a consomic control that is genetically identical except for introgression of chromosome 1. PAH began after 20 weeks of age, causing death by &60 weeks. FHR/BN1 did not develop PAH. FHR pulmonary arterial smooth muscle cells (PASMCs) had a rarified reticulum of hyperpolarized mitochondria with reduced expression of electron transport chain components and superoxide dismutase-2. These mitochondrial abnormalities preceded PAH and persisted in culture. Depressed mitochondrial reactive oxygen species (ROS) production caused normoxic activation of hypoxia inducible factor (HIF-1{alpha}), which then inhibited expression of oxygen-sensitive, voltage-gated K+ channels (eg, Kv1.5). Disruption of this mitochondrial-HIF-Kv pathway impaired oxygen sensing (reducing hypoxic pulmonary vasoconstriction, causing polycythemia), analogous to the pathophysiology of chronically hypoxic Sprague-Dawley rats. Restoring ROS (exogenous H2O2) or blocking HIF-1{alpha} activation (dominant-negative HIF-1{alpha}) restored Kv1.5 expression/function. Dichloroacetate, a mitochondrial pyruvate dehydrogenase kinase inhibitor, corrected the mitochondrial-HIF-Kv pathway in FHR-PAH and human PAH PASMCs. Oral dichloroacetate regressed FHR-PAH and polycythemia, increasing survival. Chromosome 1 genes that were dysregulated in FHRs and relevant to the mitochondria-HIF-Kv pathway included HIF-3{alpha} (an HIF-1{alpha} repressor), mitochondrial cytochrome c oxidase, and superoxide dismutase-2. Like FHRs, human PAH-PASMCs had dysmorphic, hyperpolarized mitochondria; normoxic HIF-1{alpha} activation; and reduced expression/activity of HIF-3{alpha}, cytochrome c oxidase, and superoxide dismutase-2.

Conclusions— FHRs have a chromosome 1 abnormality that disrupts a mitochondria-ROS-HIF-Kv pathway, leading to PAH. Similar abnormalities occur in idiopathic human PAH. This study reveals an intersection between oxygen-sensing mechanisms and PAH. The mitochondria-ROS-HIF-Kv pathway offers new targets for PAH therapy.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
T. van Haaften, R. Byrne, S. Bonnet, G. Y. Rochefort, J. Akabutu, M. Bouchentouf, G. J. Rey-Parra, J. Galipeau, A. Haromy, F. Eaton, et al.
Airway Delivery of Mesenchymal Stem Cells Prevents Arrested Alveolar Growth in Neonatal Lung Injury in Rats
Am. J. Respir. Crit. Care Med., December 1, 2009; 180(11): 1131 - 1142.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. R. Stenmark, B. Meyrick, N. Galie, W. J. Mooi, and I. F. McMurtry
Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure
Am J Physiol Lung Cell Mol Physiol, December 1, 2009; 297(6): L1013 - L1032.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Roth, M. Rupp, S. Hofmann, M. Mittal, B. Fuchs, N. Sommer, N. Parajuli, K. Quanz, D. Schubert, E. Dony, et al.
Heme Oxygenase-2 and Large-Conductance Ca2+-activated K+ Channels: Lung Vascular Effects of Hypoxia
Am. J. Respir. Crit. Care Med., August 15, 2009; 180(4): 353 - 364.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
P. Dromparis and E. D. Michelakis
A redox-metabolic-electrical remodeling in the diseased left and right ventricle: direct clinical implications in heart disease and beyond. Focus on "Role of {gamma}-glutamyl transpeptidase in redox regulation of K+ channel remodeling in postmyocardial infarction rat hearts"
Am J Physiol Cell Physiol, August 1, 2009; 297(2): C231 - C234.
[Full Text] [PDF]


Home page
Physiol. GenomicsHome page
D. R. Prows, A. V. Winterberg, W. J. Gibbons Jr., B. B. Burzynski, C. Liu, and T. G. Nick
Reciprocal backcross mice confirm major loci linked to hyperoxic acute lung injury survival time
Physiol Genomics, July 9, 2009; 38(2): 158 - 168.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
N. W. Morrell, S. Adnot, S. L. Archer, J. Dupuis, P. Lloyd Jones, M. R. MacLean, I. F. McMurtry, K. R. Stenmark, P. A. Thistlethwaite, N. Weissmann, et al.
Cellular and molecular basis of pulmonary arterial hypertension.
J. Am. Coll. Cardiol., June 30, 2009; 54(1 Suppl): S20 - S31.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. V. McLaughlin, S. L. Archer, D. B. Badesch, R. J. Barst, H. W. Farber, J. R. Lindner, M. A. Mathier, M. D. McGoon, M. H. Park, R. S. Rosenson, et al.
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association Developed in Collaboration With the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association
J. Am. Coll. Cardiol., April 28, 2009; 53(17): 1573 - 1619.
[Full Text] [PDF]


Home page
CirculationHome page
Writing Committee Members, V. V. McLaughlin, S. L. Archer, D. B. Badesch, R. J. Barst, H. W. Farber, J. R. Lindner, M. A. Mathier, M. D. McGoon, M. H. Park, et al.
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: Developed in Collaboration With the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association
Circulation, April 28, 2009; 119(16): 2250 - 2294.
[Full Text] [PDF]


Home page
Eur Respir JHome page
E. D. Michelakis
Soluble guanylate cyclase stimulators as a potential therapy for PAH: enthusiasm, pragmatism and concern
Eur. Respir. J., April 1, 2009; 33(4): 717 - 721.
[Full Text] [PDF]


Home page
HypertensionHome page
S. H.H. Chan, K. L.H. Wu, A. Y.W. Chang, M.-H. Tai, and J. Y.H. Chan
Oxidative Impairment of Mitochondrial Electron Transport Chain Complexes in Rostral Ventrolateral Medulla Contributes to Neurogenic Hypertension
Hypertension, February 1, 2009; 53(2): 217 - 227.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. Poburko, C.-H. Liao, C. van Breemen, and N. Demaurex
Mitochondrial Regulation of Sarcoplasmic Reticulum Ca2+ Content in Vascular Smooth Muscle Cells
Circ. Res., January 2, 2009; 104(1): 104 - 112.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
N. Sommer, A. Dietrich, R. T. Schermuly, H. A. Ghofrani, T. Gudermann, R. Schulz, W. Seeger, F. Grimminger, and N. Weissmann
Regulation of hypoxic pulmonary vasoconstriction: basic mechanisms
Eur. Respir. J., December 1, 2008; 32(6): 1639 - 1651.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Y.-B. Shui, J. M. Arbeit, R. S. Johnson, and D. C. Beebe
HIF-1: An Age-Dependent Regulator of Lens Cell Proliferation
Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 4961 - 4970.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. J Zhang, P. T Toth, D. Urboniene, and S. L Archer
Abstract 2625: The Demethylating Agent 5-aza-2'deoxycytidine (Decitabine) Restores Superoxide Dismutase 2 (SOD2) Expression and Reactive Oxygen Species Production in the Pulmonary Arteries of Fawn-hooded Rats with Pulmonary Hypertension
Circulation, October 28, 2008; 118(18_MeetingAbstracts): S_755 - S_756.



Home page
CirculationHome page
E. D. Michelakis, M. R. Wilkins, and M. Rabinovitch
Emerging Concepts and Translational Priorities in Pulmonary Arterial Hypertension
Circulation, September 30, 2008; 118(14): 1486 - 1495.
[Full Text] [PDF]


Home page
CirculationHome page
G. Kwapiszewska, M. Wygrecka, L. M. Marsh, S. Schmitt, R. Trosser, J. Wilhelm, K. Helmus, B. Eul, A. Zakrzewicz, H. A. Ghofrani, et al.
Fhl-1, a New Key Protein in Pulmonary Hypertension
Circulation, September 9, 2008; 118(11): 1183 - 1194.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. J. Rey-Parra, S. L. Archer, R. D. Bland, K. H. Albertine, D. P. Carlton, S.-C. Cho, B. Kirby, A. Haromy, F. Eaton, X. Wu, et al.
Blunted Hypoxic Pulmonary Vasoconstriction in Experimental Neonatal Chronic Lung Disease
Am. J. Respir. Crit. Care Med., August 15, 2008; 178(4): 399 - 406.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Nagendran, V. Gurtu, D. Z. Fu, J. R.B. Dyck, A. Haromy, D. B. Ross, I. M. Rebeyka, and E. D. Michelakis
A dynamic and chamber-specific mitochondrial remodeling in right ventricular hypertrophy can be therapeutically targeted
J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 168 - 178.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. P. Mehta, J. L. Campian, J. Guardiola, J. A. Cabrera, E. K. Weir, and J. W. Eaton
Generation of Oxidants by Hypoxic Human Pulmonary and Coronary Smooth-Muscle Cells
Chest, June 1, 2008; 133(6): 1410 - 1414.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. J. Mingone, M. Ahmad, S. A. Gupte, J. L. Chow, and M. S. Wolin
Heme oxygenase-1 induction depletes heme and attenuates pulmonary artery relaxation and guanylate cyclase activation by nitric oxide
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1244 - H1250.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
E. K. Weir, M. Obreztchikova, and Z. Hong
Fenfluramine: riddle or Rosetta stone?
Eur. Respir. J., February 1, 2008; 31(2): 232 - 235.
[Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. M. Whitman, S. Pisarcik, T. Luke, M. Fallon, J. Wang, J. T. Sylvester, G. L. Semenza, and L. A. Shimoda
Endothelin-1 mediates hypoxia-induced inhibition of voltage-gated K+ channel expression in pulmonary arterial myocytes
Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L309 - L318.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. L. Archer, M. Gomberg-Maitland, M. L. Maitland, S. Rich, J. G. N. Garcia, and E. K. Weir
Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1{alpha}-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H570 - H578.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. S. McMurtry, S. Bonnet, E. D. Michelakis, S. Bonnet, A. Haromy, and S. L. Archer
Statin therapy, alone or with rapamycin, does not reverse monocrotaline pulmonary arterial hypertension: the rapamcyin-atorvastatin-simvastatin study
Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L933 - L940.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Bonnet, G. Rochefort, G. Sutendra, S. L. Archer, A. Haromy, L. Webster, K. Hashimoto, S. N. Bonnet, and E. D. Michelakis
The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted
PNAS, July 3, 2007; 104(27): 11418 - 11423.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. B. Sehgal and S. Mukhopadhyay
Pulmonary arterial hypertension: a disease of tethers, SNAREs and SNAPs?
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H77 - H85.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
G. Y. Rochefort and E. D. Michelakis
COUNTERPOINT: RELEASE OF AN ENDOTHELIUM-DERIVED VASOCONSTRICTOR AND RHOA/RHO KINASE-MEDIATED CALCIUM SENSITIZATION OF SMOOTH MUSCLE CELL CONTRACTION ARE NOT THE MAIN EFFECTORS FOR FULL AND SUSTAINED HPV
J Appl Physiol, May 1, 2007; 102(5): 2072 - 2075.
[Full Text] [PDF]


Home page
CirculationHome page
H. Kajimoto, K. Hashimoto, S. N. Bonnet, A. Haromy, G. Harry, R. Moudgil, T. Nakanishi, I. Rebeyka, B. Thebaud, E. D. Michelakis, et al.
Oxygen Activates the Rho/Rho-Kinase Pathway and Induces RhoB and ROCK-1 Expression in Human and Rabbit Ductus Arteriosus by Increasing Mitochondria-Derived Reactive Oxygen Species: A Newly Recognized Mechanism for Sustaining Ductal Constriction
Circulation, April 3, 2007; 115(13): 1777 - 1788.
[Abstract] [Full Text] [PDF]